Association of OPG genotypes with their serum levels in Iraqi type 2 diabetic patients

Abstract

Type 2 diabetes mellitus(T2DM) is an prevalent multifactorial disease that has both genetic and environmental risk factors, resulting in impaired glucose homeostasis. Osteoprotegerin (OPG) is a secretory glycoprotein that belongs to the Tumor Necrosis Factor (TNF) receptor family and involves in the regulation of bone metabolism, ectopic calcification including vascular calcification processes, and endothelium regeneration. OPG is also referred to by its acronym. It is involved in ectopic calcification, which includes vascular calcification and endothelium renewal, and affects bone metabolism. Common genetic variations that are functionally significant can be found in the OPG gene, which codes for the protein. Type 2 diabetics have higher osteoprotegerin concentrations than non-diabetic subjects. OPG has the potential to function as a biomarker for type 2 diabetes. This study aims to investigate the association of polymorphism of OPG gene T950>C (rs2073617) gene to their serum levels among Iraqi patients. Using a suitable sample procedure, 65 volunteers (40 verified type 2 diabetic patients and 25 healthy Genetic polymorphism of Osteoprotegerin (OPG) gene T950>C (rs2073617) was carried out using RFLP-PCR. Serum levels of OPG were performed using by enzyme-linked immunosorbent assay technique (ELISA) using a Human- OPG kit. Based on the polymorphism of OPG gene T950>C, serum levels of OPG were higher among Type2DM patients with TT and CC genotypes than that with TC genotypes (TT, 2.6764±0.64032, CC 3.4532±1.80736 and TC 1.6103±0.07901, P 0.05. Polymorphism of the Osteoprotegerin (OPG) gene T950>C (rs2073617) can be associated with the serum levels of OPG among Type2DM patients.

Keywords

• OPG gene T950>C, T2DM , PCR, ELISA